| Serial Number | 79307220 |
| Word Mark | ARVIDAL |
| Filing Date | Friday, December 11, 2020 |
| Status | 604 - ABANDONED - AFTER INTER-PARTES DECISION |
| Status Date | Monday, March 14, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, November 2, 2021 |
| Goods and Services | pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely, by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses being Alpha-, Beta-, Gamma- and Deltacoronaviruses, severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology being multiple viral infections; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Monday, March 14, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PVP LABS PTE. LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | SG |
| Party Name | PVP LABS PTE. LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | SG |
| Event Date | Event Description |
| Wednesday, April 5, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, March 14, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, March 14, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, October 31, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, October 12, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 12, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, March 15, 2022 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION |
| Monday, March 14, 2022 | ABANDONMENT - AFTER INTER PARTES DECISION |
| Monday, March 14, 2022 | OPPOSITION TERMINATED NO. 999999 |
| Monday, March 14, 2022 | OPPOSITION SUSTAINED NO. 999999 |
| Monday, December 13, 2021 | REFUSAL PROCESSED BY IB |
| Monday, November 22, 2021 | OPPOSITION INSTITUTED NO. 999999 |
| Tuesday, November 16, 2021 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| Tuesday, November 16, 2021 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| Monday, November 15, 2021 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Tuesday, November 2, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 2, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 13, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 28, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, September 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 27, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 27, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, July 24, 2021 | REFUSAL PROCESSED BY IB |
| Friday, July 2, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, July 2, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, July 2, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, July 1, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, June 24, 2021 | ASSIGNED TO EXAMINER |
| Friday, June 4, 2021 | ASSIGNED TO EXAMINER |
| Thursday, June 3, 2021 | ASSIGNED TO EXAMINER |
| Thursday, May 13, 2021 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Monday, May 10, 2021 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, April 2, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 29, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 25, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |